Guinea vs Israel: HIV-positive TB patients on ART (antiretroviral therapy)
Guinea
100.0%
in 2024
Israel
100.0%
in 2024
Guinea rank
1st
Israel rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Guinea
- Israel
How they compare
Guinea currently reports 100.0% against 100.0% in Israel, a difference of 0.0%.
The two have swapped places 2 times across 12 shared years of data; in 2008 it was Israel ahead.
Guinea ranks 1st and Israel ranks 1st of 144 countries.
Across the 3 decades both report, Guinea averaged higher in 1 and Israel in 2.
Head to head by decade
| Decade | Guinea | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.2% | 68.0% | 52.8% | Israel |
| 2010s | 83.8% | 100.0% | 16.2% | Israel |
| 2020s | 98.6% | 98.2% | 0.4% | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Guinea or Israel?
- Guinea, at 100.0% against 100.0% in Israel as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Guinea and Israel?
- 0.0%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Israel?
- 12 years are reported by both, from 2008 to 2024.
- How do Guinea and Israel rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Guinea ranks 1st and Israel ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.